Nurix (NRIX) trades up 20%, RBC says agreement with Roche removes some overhangs, 'We remain buyers'
Tweet Send to a Friend
(Updated - June 8, 2026 9:42 AM EDT)
RBC Capital analyst Brian Abrahams reiterated an Outperform rating and $30.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams reiterated an Outperform rating and $30.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
